Phase 2 Trial Of Oxford COVID-19 Vaccine Candidate To Begin Today
Serum Institute of India has partnered with British-Swedish pharma corporate AstraZeneca. (Document) New Delhi: The section 2 human medical trial
Read More
human clinical trial